ClinicalTrials.gov
public full text
Public Domain
Biomarkers and Early Alzheimer's Disease
The main goal of this project is to use imaging and biomarkers to identify cognitively normal elderly people who are at increased risk for developing mild cognitive impairment (MCI). MCI is the earliest clinically detectable evidence for brain changes due to Alzheimer's disease (AD). The second goal of this project is to describe the inter-relationships among anatomical biomarkers, cerebrospinal fluid biomarkers, and cognition measures in those elderly people who develop MCI.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays#8121
- Eye Tracking for Early Identification of Post-ICU Cognitive Impairment#1058170
- Large-scale Multi-omics Analysis of Cerebrospinal Fluid#896162
- Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors#1161659
- Multimodal neuroimaging approach for cognitive impairment in Alzheimer disease#341970
Record · ID 1088574
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive